OptimizeRx to Present at the 5th Annual Liolios Gateway Conference on September 7, 2016

ROCHESTER, Mich., Aug. 25, 2016 -- OptimizeRx Corp. (OTCQB:OPRX), a health technology software company whose premier content-delivery platform enables pharmaceutical companies to provide on-demand patient-care has been invited to present at the 2016 Gateway Conference being held on September 7-8, 2016 at the Four Seasons Hotel San Francisco.

OptimizeRx CEO William Febbo is scheduled to present on Wednesday, September 7 at 8:30 a.m. Pacific time, with one-on-one meetings held throughout the day.

He will discuss continued growth in both pharmaceutical brands and its distribution network and provide an update on its partnership with WPP, the largest marketing services company in the world.

The presentation will be webcast live at: http://wsw.com/webcast/liolios2/oprx and available for replay on the Gateway Conference website at www.gateway-conference.com/presenters.

To receive additional information, request an invitation or to schedule a one-on-one meeting, please email [email protected].

About the Gateway Conference
The 5^th Annual Gateway Conference is an invite-only conference presented by Liolios, which brings together the most compelling companies with the nation’s top institutional investors and analysts. This year’s event features more than 100 companies from a number of growth industries, including technology, business and financial services, consumer, digital media, clean technology and life sciences. The format has been designed to give attendees direct access to senior management via company presentations, Q&A sessions and one-on-one meetings. For more information, visit www.gateway-conference.com or www.liolios.com.

 About OptimizeRx Corp
OptimizeRx Corporation (OTCQB:OPRX) provides unique consumer and physician platforms to help patients better afford and comply with their medicines and healthcare products, while offering pharmaceutical and healthcare companies effective ways to expand awareness, access and adherence to their medications.

The company’s core product, SampleMD, replaces drug samples with electronic trial vouchers and copay coupon savings that are electronically added to an e-Prescription and sent electronically to the pharmacy and is integrated within leading electronic health record (EHR) platforms in the country, including Allscripts, Quest Diagnostics, Practice Fusion and over 350 other EHRs to reach over 250,000 healthcare providers. In turn, OptimizeRx promotes patient savings and support from the world’s largest pharmaceutical companies, including Pfizer, Lilly, Novartis, AstraZeneca and many others. For more information, please go to www.optimizerxcorp.com.

Company Contact:
OptimizeRx
Doug Baker
[email protected]
248-651-6568 x807 

Investor Relations Contact:
Liolios Group
Ron Both, Senior Managing Director
[email protected] 
949-574-3860